-+ 0.00%
-+ 0.00%
-+ 0.00%

NEWCELX REPORTS FINANCIAL RESULTS FOR 2025 AND PROVIDES SHAREHOLDERS WITH UPDATE ON ACCELERATED DEVELOPMENT OF TYPE 1 DIABETES TREATMENT IN COLLABORATION WITH ELEDON PHARMACEUTICALS IN 2026

Reuters·04/30/2026 12:15:00

Please log in to view news